Jennifer Doudna, one of the inventors of the breakthrough gene-editing tool CRISPR, says the technology will help the world ...

Researchers have identified a particular cellular protein that affects aging. They’ve also managed to tweak this gene to ...

The end of SRP-5051 is disappointing, according to analysts, but Elevidys' trajectory should more than make up for it. Sales ...

Professor Carsten Carlberg has published a comprehensive new textbook, "Gene Regulation and Epigenetics: How Science Works," ...

Gene Munster, Deepwater Asset Management, talks what a Trump presidency means for Tesla. How Did California Vote on Gavin ...

Elliott and McCoy are two of just six Team USA senior players on the men's side. The fifth edition of the ...

Beam Therapeutics enrolls 35 patients in BEACON trial for BEAM-101 in sickle cell disease, with promising early safety and ...

Paxton Purdy's parents said he has an ultra-rare neurodegenerative genetic mutation. They hope they can raise enough money to ...

Researchers have identified a specific protein within genetic code that, if tweaked, can extend life by up to 30%, which ...

Every autumn, thousands flock to Gene's farm for pumpkins, making memories and a new friend. Here's the story of a man ...

It's never a good sign for NFL officials if Gene Steratore is disagreeing with your call. The former referee turned CBS ...

Needham analyst Gil Blum maintained a Buy rating on Taysha Gene Therapies (TSHA – Research Report) today and set a price target of $6.00.